e-learning
resources
Virtual 2020
Pre-Congress Content
Translational science in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Condition of cellular immunity in patients with prolonged course of community acquired pneumonia
R. Razumnyi (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine)
Source:
Virtual Congress 2020 – Translational science in respiratory infections
Session:
Translational science in respiratory infections
Session type:
E-poster session
Number:
2328
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Razumnyi (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine). Condition of cellular immunity in patients with prolonged course of community acquired pneumonia. 2328
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Clinical presentation and evolution of community acquired pneumonia in older patients
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period
Source: Eur Respir J 2006; 28: Suppl. 50, 165s
Year: 2006
The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 579s
Year: 2005
Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP)
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
The role of procoagulant activity in patients with community acquired pneumonia
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Imaging patterns of bacterial community acquired pneumonia in moderately immunocompromised patients
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Community acquired pneumonia in COPD patients: ?linical features and peculiarities of immune system
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 669s
Year: 2006
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Source: Eur Respir J 2001; 18: 362-368
Year: 2001
Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
Assessment of humoral immune response and the incidence of acquired infections in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 174s
Year: 2003
Using roncoleukine in basic therapy of patients with community acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 443s
Year: 2002
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Frequency of antibiotic resistance and outcomes in severe community acquired pneumonia due to
Streptococcus pneumoniae
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Postexpiratory pause reflects breathing control in patients with community acquired pneumonia
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Viral infection in adult hospitalized with community acquired pneumonia
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010
Influence of medical comorbidities in patients with community acquired pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Virusologic research in healthy persons of closed collectives
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept